Includes the number of amines tested and the method of analysis.
This patient’s result is POSITIVE, which indicates the patient has at least one metabolic subtype (metabotype) associated with ASD. This section may include additional findings about individual amine levels.
Note: The positive or negative result is based on algorithmic analysis that compares certain amines levels to each other.
For this patient, follow-up with neurodevelopmental specialist is recommended. We also recommend researching the recommendations in the references and/or referring your patient to a metabolic specialist for further evaluation.
This table shows levels of 32 individual amines. Some individual amine levels may be outside the normal range, although no metabotypes associated with ASD were identified.
Test was developed using fasting blood plasma samples from children 18-48 months old. A child who receives a NEGATIVE result on this test may go on to be diagnosed with ASD. About 53% of children with ASD will receive a positive result on the NPDX ASD test.
Additional research, including NeuroPointDX’s paper on its 1,100-patient autism research study, are listed on the last page of the report.